Stockreport

Synlogic Presents Data from Immuno-Oncology Development Program Demonstrating Potent Anti-Tumor Immunity Following Administration of Novel STING Agonist-producing Synthetic Biotic™ Medicin...

Synlogic, Inc.  (SYBX) 
Last synlogic, inc. earnings: 3/12 04:19 pm Check Earnings Report
PDF - Data presented at Keystone Symposium demonstrate rapid tumor rejection in preclinical models - - Data support advancement of Synthetic Biotic medicines [Read more]